Home > Boards > US Listed > Biotechs >

Aclaris Therapeutics, Inc. (ACRS)

ACRS RSS Feed
Add ACRS Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 1/20/2021 5:19:02 PM - Followers: 12 - Board type: Free - Posts Today: 0

Trading BRUTAL under Cash balance , super hot Rebound Play

Market Cap $43 M / Cash $115 M or untill end 2021 / 2 APPROVED Products / 1 Phase 3 trial (common warts) with results expected in Q4 2019 and many other phase 2 programs / because of their strategic change they wants to out-license all their Prodcuts which means HUGE upfront payments for the company (more infos below)= CHEAPEST Biotech you can get at this time could triple easily ..


Aclaris Therapeutics (ACRS)

Market Cap: $43 M
Cash: $115 M or enough untill end 2021 EXCLUDING Upfront payments from Out-licensing and royalties
Price: $1.08

Book Value: $3.30
Cash per Share: $2.79


Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Pivotal Phase 3 Trial for the Treatment of Common Warts (THWART-2)...
September 16, 2019
https://investor.aclaristx.com/news-releases/news-release-details/aclaris-therapeutics-101-45-topical-solution-meets-primary-and-0

“There are no FDA approved prescription treatments for common warts and we are excited by these data and look forward to the results of the second pivotal Phase 3 trial, THWART-1 (WART-301),” said Dr. Neal Walker, President and CEO of Aclaris.
Common warts, also called verruca vulgaris, are skin growths caused by a virus infecting the top layer of the skin. They affect an estimated 22 million Americans each year with a higher incidence in children than adults.



Morgan Stanley reports 5% passive stake in Aclaris Therapeutics...08/29,2019
https://thefly.com/landingPageNews.php?id=2956902


Aclaris Therapeutics Announces New Strategic Direction
https://investor.aclaristx.com/news...herapeutics-announces-new-strategic-direction


This new strategic direction includes the following actions:

Actively Seeking a Commercialization Partner for RHOFADE® (oxymetazoline hydrochloride) cream, 1%

Aclaris will also seek strategic partners for ESKATA® (hydrogen peroxide) topical solution, 40% (w/w)


Aclaris is actively seeking a strategic partner to commercialize its drug candidate A-101 45% Topical Solution, an investigational compound being developed as a potential treatment for verruca vulgaris (common warts). The Company’s two ongoing Phase 3 pivotal clinical trials, THWART-1 and THWART-2, in which A-101 45% Topical Solution is being evaluated as a potential treatment for common warts, are progressing as planned. Aclaris has completed enrollment of more than 1,000 patients across these two trials, and data from both trials are expected in the second half of 2019.

Aclaris is actively seeking a development and commercialization partner for its drug candidates, ATI-501 (oral) and ATI-502 (topical), which are investigational Janus Kinase (JAK) 1/3 inhibitor compounds for the potential treatment of alopecia.


ACRS aquired a attractive drug from Allergan last year paid $65 m upfront alone for this drug which they now looking to outlicense .

https://www.globenewswire.com/news-...orldwide-Rights-to-RHOFADE-from-Allergan.html


Pipeline
https://www.aclaristx.com/pipeline/


Largest Shareholders:

Deerfield Management Company LP...5 893 416
Franklin Advisers, Inc....3 953 203
BlackRock Fund Advisors ...2 359 223
Broadfin Capital LLC...2 280 260
D. E. Shaw & Co. LP....2 049 462
Sofinnova Ventures, Inc.....1 911 573
Vivo Capital LLC ....1 647 214
Fidelity Management & Research Co...1 562 190
Polar Capital LLP...1 443 920
The Vanguard Group, Inc...1 142 022










 
ACRS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ACRS News: Statement of Changes in Beneficial Ownership (4) 05/07/2021 06:28:35 PM
ACRS News: Securities Registration: Employee Benefit Plan (s-8) 05/07/2021 04:45:42 PM
ACRS News: Aclaris Therapeutics EPS misses by $0.29, beats on revenue 05/07/2021 07:39:48 AM
ACRS News: Quarterly Report (10-q) 05/07/2021 07:31:38 AM
ACRS News: Current Report Filing (8-k) 05/07/2021 07:16:21 AM
PostSubject
#313   I was short premarket 20.30 then quickly covered alchemytrader 01/20/21 05:19:02 PM
#312   ACRS offering more than 5m shares at $17.50/per share SteevoTrader 01/20/21 09:01:58 AM
#311   The way she kept grinding back to 19s alchemytrader 01/19/21 11:50:21 PM
#310   Are we seeing a dump tomorrow? SteevoTrader 01/19/21 08:57:36 PM
#309   Oh really? hit 19.95 today... alchemytrader 01/19/21 07:55:29 PM
#308   * * $ACRS Video Chart 01-19-2021 * * ClayTrader 01/19/21 05:40:22 PM
#307   One month later. Take a look now. E-trade Marketwise 01/19/21 12:37:35 PM
#306   Nice! Docstemcell2020 01/19/21 09:28:03 AM
#305   Im so happy Etrade wouldnt let me buy Serge521 12/22/20 10:49:15 AM
#304   So ACRS trials will take 2 years but interloper 08/20/20 11:55:50 AM
#303   ACRS Trials gets an update from the FDA. DanSanTrades 08/17/20 10:06:19 AM
#302   * * $ACRS Video Chart 07-20-2020 * * ClayTrader 07/20/20 05:33:46 PM
#301   * * $ACRS Video Chart 06-17-2020 * * ClayTrader 06/17/20 04:16:47 PM
#300   * * $ACRS Video Chart 01-10-2020 * * ClayTrader 01/10/20 03:58:13 PM
#299   good Volume beambe 01/10/20 10:36:29 AM
#298   Just a shout out here, anyone with fundamental XenaLives 12/26/19 08:05:35 AM
#297   3 Penny Stocks To Watch As Biotech Hits jonny_red 10/31/19 08:39:32 AM
#296   * * $ACRS Video Chart 10-29-2019 * * ClayTrader 10/29/19 04:43:51 PM
#295   $ACRS Overbought Aclaris Therapeutics (ACRS) May Report Negative Earnings SpotOnTrade 10/29/19 03:06:15 PM
#294   3 Best Penny Stocks To Trade Before Next jonny_red 10/28/19 10:34:19 AM
#293   ~2.00+ SQUUUUEEEEEZEEE VMB-1 10/25/19 11:31:57 AM
#292   ~in @1.83...Gonna Spike new HOD.. VMB-1 10/25/19 09:57:46 AM
#291   the shorts will have to cover over 4mm dndodd 10/25/19 09:19:50 AM
#290   Sold 1/3 of shares in after market @ Neverland66 10/25/19 08:46:47 AM
#289   WOW!! toybaby 10/25/19 08:05:37 AM
#288   ~Buy AfterHours for another Halt Spike AM 2morrow? VMB-1 10/24/19 06:45:39 PM
#287   Positive phase 3 news just out ! stock1ace1 10/24/19 05:02:15 PM
#286   News ! stock1ace1 10/24/19 04:51:43 PM
#284   * * $ACRS Video Chart 10-22-2019 * * ClayTrader 10/22/19 04:17:40 PM
#283   1.73 toybaby 10/17/19 07:32:27 AM
#282   We should see $2.08 as next resistance AugustaFriends 10/16/19 08:40:56 AM
#281   1.70 p/m stock1ace1 10/16/19 08:22:09 AM
#280   I am impressed toybaby 10/16/19 07:16:32 AM
#279   Arkin Moshe discloses 8.02% activist ownership in ACRS ADVFN_bioking 10/15/19 05:40:46 PM
#278   1.50 up toybaby 10/15/19 01:46:22 PM
#277   I still do things like that I sold toybaby 10/15/19 08:29:50 AM
#276   A novice trader sold pm @1.25 im dead stock1ace1 10/15/19 08:06:35 AM
#275   Easily attainable toybaby 10/15/19 08:00:43 AM
#274   Need to push thru 1.50$ today stock1ace1 10/15/19 07:41:25 AM
#273   Great News !! Timetravelerdos 10/14/19 05:39:55 PM
#272   agree```` will hope by toybaby 10/14/19 01:47:36 PM
#271   Some big $ on bids ! Going up stock1ace1 10/14/19 01:34:54 PM
#270   Slow n steady :) shorts will cover end stock1ace1 10/14/19 01:01:28 PM
#269   WOW!! toybaby 10/14/19 12:55:50 PM
#268   1.50 :-D Crazy Money 10/14/19 12:48:06 PM
#267   *** Short Squeeze **** stock1ace1 10/14/19 09:39:46 AM
#266   Gap at 3$ - $4.32 area stock1ace1 10/14/19 07:46:54 AM
#265   1.44 p/‘m stock1ace1 10/14/19 07:11:04 AM
#264   Acrs already cutting staff saving $$ Aclaris is stock1ace1 10/13/19 04:38:00 PM
#263   Did anybody looks at this chart ~> https://finviz.com/quote.ashx?t=ACRS Can stock1ace1 10/13/19 03:43:08 PM
PostSubject
Consent Preferences